June 27, 2013
Evonik's global lysine production capacity to hit 500,000 tonnes in 2015
Press release

Essen, Germany-based Evonik Industries is progressing according to plan with the extension of its core business of amino acids for animal feed, with the laying of the foundation stone for the new Biolys® plant in Volgodonsk (Rostov region, Russia).
The new plant will be constructed by the joint venture OOO DonBioTech, which belongs to the Russian Varshavsky Group and Evonik as a minority shareholder. It will come on stream in 2015 and have an annual capacity for Biolys® of around 100,000 tonnes.
"With the recently completed production expansion in Blair (USA), the construction of a new plant in Castro (Brazil), and the plant in Volgodonsk, we'll have an annual production capacity of 500,000 tonnes of Biolys® from 2015," said Evonik executive board member Patrik Wohlhauser.
"This will strengthen our leading position in the production of feed-grade amino acids, which are an important part of our growth strategy."
Biolys® is a efficient source of the amino acid L-lysine and is used as a feed additive in modern animal nutrition. Production in Volgodonsk is based on Evonik's fermentation technology. Wheat from the Rostov region will be used as a raw material, which the joint venture will process itself.
Evonik is the only company worldwide to produce and market all four essential amino acids for advanced animal nutrition: Biolys® (L-lysine source), MetAMINO® (DL-methionine), ThreAMINO® (L-threonine), and TrypAMINO® (L-tryptophan). The Group delivers its iservice and products to more than 100 countries.










